181
181
Jul 17, 2014
07/14
by
BLOOMBERG
tv
eye 181
favorite 0
quote 0
novartis turned in disappointing results.iate -- it reported profit and sales the shade below estimates. we are joined. analysts.140 sam, what happened then with novartis? disappointed but not buy anymore just margin -- an inner misfortune. >> it is quite difficult for to look at the orderly numbers, especially for a company such as novartis which has a cross in swiss franks. and a whole host of other currencies that are affected. you know currencies have been volatile in the past quarter. that was not the only reason. analysts overestimated how much diovan worse going to sell in the second quarter. not by much. generic. gone something that can be explained away. what is interesting as they have kept their guidance on the top line for the year, but it looks like analysts are a little bit below that guidance figure. >> tell me more about the outlook for 2014 because this is a business that is going to structural changes. >> those structural changes, you will not notice necessarily on the group numbers this year. all those deal
novartis turned in disappointing results.iate -- it reported profit and sales the shade below estimates. we are joined. analysts.140 sam, what happened then with novartis? disappointed but not buy anymore just margin -- an inner misfortune. >> it is quite difficult for to look at the orderly numbers, especially for a company such as novartis which has a cross in swiss franks. and a whole host of other currencies that are affected. you know currencies have been volatile in the past...
124
124
Jul 17, 2014
07/14
by
BLOOMBERG
tv
eye 124
favorite 0
quote 0
they teamed up with novartis. we look at the future of wearable electronics.er the break. ♪ >> welcome back. let's give you a quick check on some of the foreign exchange markets as london picks up. just off four-week highs. more dovish.ther we get housing starts and that will dictate some of the momentum you see there. let's have a look at dollar-yen. to by hsbc as the most boring currency in the world. the yen gaining and we have equity futures declining. begin toe u.s. futures accept and understand what is going on with u.s. sanctions on russia, playing into more of a haven trade. those of the currency -- those are the currencies. let's give you headlines. present -- president obama and the eu impose more sanctions on russia. this time targeting tanks and defense firms in the latest -- and banks and defense firms and the attempt to punish russia. >> where blocking new financing of some of russia's most important banks and energy companies. these are significant but they're also targeted, designed to have the maximum impact on russia while limiting spillover
they teamed up with novartis. we look at the future of wearable electronics.er the break. ♪ >> welcome back. let's give you a quick check on some of the foreign exchange markets as london picks up. just off four-week highs. more dovish.ther we get housing starts and that will dictate some of the momentum you see there. let's have a look at dollar-yen. to by hsbc as the most boring currency in the world. the yen gaining and we have equity futures declining. begin toe u.s. futures accept...
81
81
Jul 17, 2014
07/14
by
BLOOMBERG
tv
eye 81
favorite 0
quote 0
novartis missed estimates.er was dragged down by declining sales in the that scene unit it is selling. unit it isine selling. thanks for joining us. they did not impress in a positive business they are selling. away is theou take important conclusions to come out of these numbers today? that they say first do not really miss estimates. they were a touch below by 1% on the top and bottom line. it is a very small miss. what we have to focus on is the -- key division which is pharmaceutical. former have seen is the margins have increased by 2 percentage points and that is a positive benefit from the lacck .competition . >> talking of lens. alcon. some interesting deals they have been announcing with google. lens technology being licensed from google. tell us about the applications this technology could be put to. >> yeah. i think it is -- exactly, a very interesting deal. i would see for both sides -- say for both sides. as novartis is the leader in ophthalmology. so it makes total sense to do an agreement between
novartis missed estimates.er was dragged down by declining sales in the that scene unit it is selling. unit it isine selling. thanks for joining us. they did not impress in a positive business they are selling. away is theou take important conclusions to come out of these numbers today? that they say first do not really miss estimates. they were a touch below by 1% on the top and bottom line. it is a very small miss. what we have to focus on is the -- key division which is pharmaceutical....
133
133
Jul 19, 2014
07/14
by
KCSM
tv
eye 133
favorite 0
quote 0
novartis oncology strives to become the world's premier oncology business by consistently discoveringdeveloping, and making novel therapies that may improve and extend the lives of people living with cancer. and by incyte corporation. incyte's vision is to become a leading biopharmaceutical company focused on improving the lives of patients with serious unmet medical needs. additional funding provided by: abbott. ironwood pharmaceuticals. janssen pharmaceuticals inc. >> mcfarland: puberty is the stage that marks the transition between childhood and adulthood. going through puberty is awkward enough for most teenagers, so just imagine a five- or six-year-old child showing clear physical signs of early development. but that's exactly what can happen with a condition known as precocious puberty. jaime and lee weir are proud parents of 14-year-old rebecca, 11-year-old rachel, and 9-year-old alicia. they are a vibrant, happy family, but the weirs have something not all families have: hereditary precocious puberty. >> rachel goes second. i had never heard of it. >> you know your kids from o
novartis oncology strives to become the world's premier oncology business by consistently discoveringdeveloping, and making novel therapies that may improve and extend the lives of people living with cancer. and by incyte corporation. incyte's vision is to become a leading biopharmaceutical company focused on improving the lives of patients with serious unmet medical needs. additional funding provided by: abbott. ironwood pharmaceuticals. janssen pharmaceuticals inc. >> mcfarland: puberty...
90
90
Jul 26, 2014
07/14
by
KCSM
tv
eye 90
favorite 0
quote 0
novartis oncology strives to become the world's premier oncology business by consistently discoveringeveloping, and making novel therapies that may improve and extend the lives of people living with cancer. and by incyte corporation. incyte's vision is to become a leading biopharmaceutical company focused on improving the lives of patients with serious unmet medical needs. additional funding provided by: abbott. ironwood pharmaceuticals. janssen pharmaceuticals inc. >> mcfarland: myelofibrosis is thought of as a type of chronic leukemia where bone marrow is slowly replaced with scar tissue, or fibrous tissue. this scarring process gradually disrupts the body's normal production of blood cells and platelets. depending on the severity of the scarring, there are consequences such as anemia, weakness, extreme fatigue, and an enlarged spleen or liver. and though as of today there's no cure, recent success has been made in the treatment of myelofibrosis. >> myelofibrosis is a complicated term for a simple thing, which means scarring of the bone marrow. >> mcfarland: dr. hagop kantarjian is
novartis oncology strives to become the world's premier oncology business by consistently discoveringeveloping, and making novel therapies that may improve and extend the lives of people living with cancer. and by incyte corporation. incyte's vision is to become a leading biopharmaceutical company focused on improving the lives of patients with serious unmet medical needs. additional funding provided by: abbott. ironwood pharmaceuticals. janssen pharmaceuticals inc. >> mcfarland:...
129
129
Jul 15, 2014
07/14
by
BLOOMBERG
tv
eye 129
favorite 0
quote 0
google is teaming up with novartis to develop smart contact lenses.e able to monitor insulin levels for people with diabetes and offer focus for people who can no longer read without glasses. microsoft is planning its biggest round of job cuts and five years. it's trying to slim down. working to integrate nokia's handset unit. reductions could be announced this week. hewlett-packard says that their interim chairman has resigned from the board to focus on his health issues. hp will discuss appointing a new chairman in its next board meeting. the resignation goes into effect tomorrow. that is the latest in tech. and another atlantic city casino has fallen, putting 1000 people out of work. trump plaza will shut its september following in the footsteps of showboat and billion casino that file for bankers c for a second time in two years last month. joining us for more is the ceo of penn national gaming which operates gaming and racing facilities. he is the former chief operating officer of harrah's. also with us is our analyst brian miller who covers the
google is teaming up with novartis to develop smart contact lenses.e able to monitor insulin levels for people with diabetes and offer focus for people who can no longer read without glasses. microsoft is planning its biggest round of job cuts and five years. it's trying to slim down. working to integrate nokia's handset unit. reductions could be announced this week. hewlett-packard says that their interim chairman has resigned from the board to focus on his health issues. hp will discuss...
154
154
Jul 15, 2014
07/14
by
WTXF
tv
eye 154
favorite 0
quote 0
swiss drug novartis and google teaming up to create smart couldn't tense lenses.enses will help diabetics and other people to help diabetes much the lense boss actually measure the glucose and tear fluid and send date to to mobile device. designers are working on lense that is would restore aging eyes ability to focus kind of like a camera's auto focus. novartis says it could be five years before the lenses are ready for you. >> a new study says dna helps create friendships. researchers studied to thousand friends not biologically related and this is what they found. friends genetically have more in common than strangers. they found that pairs of friends are genetically similar to fourth cousins much researchers say the most common gene shared by friends is the gene involved in person's sense of smell. the study is in the proceedings of the national academy of sciences. >>> largest event of its kind in the world. and it's coming to philadelphia. the 17th annual brave new voices international youth poetry slam festival starts tomorrow. today mayor michael nutter he
swiss drug novartis and google teaming up to create smart couldn't tense lenses.enses will help diabetics and other people to help diabetes much the lense boss actually measure the glucose and tear fluid and send date to to mobile device. designers are working on lense that is would restore aging eyes ability to focus kind of like a camera's auto focus. novartis says it could be five years before the lenses are ready for you. >> a new study says dna helps create friendships. researchers...
83
83
Jul 15, 2014
07/14
by
BLOOMBERG
tv
eye 83
favorite 0
quote 0
novartis has parted with google -- partnered with google to develop smart contact lenses.would have noninvasive sensors. they will license the tech from google. it could help diabetics monitor their disease. so last century. carlos slim will pay a billion dollars to boost its share in telecom. samsung and bmw agreed to expand supply deal to make factories for the electronic vehicles. the deal is worth multi-billion of euros. it seeks a larger share of the growing demand. get ready for this. a notion of heavy metal. it may seem contradictory a first. the law of gravity savers lightweight metals. anna edwards joins us. >> thank you very much. there are things that are quite surprising. more small and medium-size businesses are there as well as the big names. those small businesses are showcasing their wares. a lot of conversation about around innovation aviation. bruce dickinson joins us now. thank you for coming to talk to us. you are holding something. >> i am holding it very carefully. this is a fantastic piece of british technology. >> it looks like an old-fashioned airs
novartis has parted with google -- partnered with google to develop smart contact lenses.would have noninvasive sensors. they will license the tech from google. it could help diabetics monitor their disease. so last century. carlos slim will pay a billion dollars to boost its share in telecom. samsung and bmw agreed to expand supply deal to make factories for the electronic vehicles. the deal is worth multi-billion of euros. it seeks a larger share of the growing demand. get ready for this. a...
358
358
Jul 15, 2014
07/14
by
FBC
tv
eye 358
favorite 0
quote 0
novartis is the parent company of alcon makes every contact lenses.ting together. that is interesting. google stock is down four bucks. that is not much on a $590 stock. >>> alibaba and lions gate entertainment are teaming up. they will launch a streaming service in china. that will be lyon's gate entertainment world. they will be exclusion sieve to juan alibaba set top boxes. they will have exclusive lions gate content like "hunger games" and "mad men." >>> alibaba is preparing to go public in the u.s. later this year. shares of lions gate entertainment are up. we'll be back in one moment. if you had chickenpox, the shingles virus is already inside you. you should know that 1 in 3 people will get shingles in their lifetime. you are gonna need a wingman. and my cash back keeps the party going. but my airline miles take it worldwide. [ male announcer ] it shouldn't be this hard. with creditcards.com, it's easy to search hundreds of cards and apply online. creditcards.com. stuart: time for the real "halftime report." we have with us nicole petallides at
novartis is the parent company of alcon makes every contact lenses.ting together. that is interesting. google stock is down four bucks. that is not much on a $590 stock. >>> alibaba and lions gate entertainment are teaming up. they will launch a streaming service in china. that will be lyon's gate entertainment world. they will be exclusion sieve to juan alibaba set top boxes. they will have exclusive lions gate content like "hunger games" and "mad men."...
118
118
Jul 16, 2014
07/14
by
WRC
tv
eye 118
favorite 0
quote 0
they have signed a deal with novartis to produce lenses. the first version will help diabetics monitor glucose levels. eventually they can treat far sightedness, too. google says the wlens mlens may day come with a built-in camera. lavar burton's character in star trek wore something similar. >> all the trekkies are supporting you. >> we saw it coming. gene roddenberry was a visionary. >>> melissa mollet is following some breaking news. >> this is the end of a police chase. this is bw parkway, 295 southbound near 32, you can see a guy here on the ground in handcuffs. apparently they tried to pull him over for reckless driving and this is the end of that. you can see the backups here, very slow as you hit 32 southbound. going to be slow for a while. they have it down to one lane because of the police presence. so just a warning. wider look at things, looking typical for this time of the morning. 270 at middlebrook, no problems there. a look at 95 in maryland coming up. >>> and as traffic is building, lower humidity is sweeping in. still a gr
they have signed a deal with novartis to produce lenses. the first version will help diabetics monitor glucose levels. eventually they can treat far sightedness, too. google says the wlens mlens may day come with a built-in camera. lavar burton's character in star trek wore something similar. >> all the trekkies are supporting you. >> we saw it coming. gene roddenberry was a visionary. >>> melissa mollet is following some breaking news. >> this is the end of a police...
214
214
Jul 16, 2014
07/14
by
WGN
tv
eye 214
favorite 0
quote 0
google is teaming up with swiss drugmaker novartis to create smart contact lenses which can track blood sugar levels. the contacts would measure glucose in tear fluid, then send the information to a wireless mobile device. it would potentially eliminate the need for finger pricks to check blood sugar levels -- which for some is necessary ten times a day. here are a few stories that are trending online this morning ... the bulls have released carlos boozer after four years. boozer was a liability on defense, and he rarely saw time in the fourth quarter last year. the bulls used the "amnesty clause" so they still owe him 16- million dollars, but it won't count against the salary cap. the bobcats, lakers, and suns are interested in him. cardinals pitcher adam wainwright had a rough time on the mound, and with his mouth, at the all-star game. he began with giving a lead-off double to derek jeter, before he allowed three runs in the first inning. later he said that he threw jeter a couple "pipe shots" because he deserved it. that was interpreted as wainwright took it easy on jeter since he's
google is teaming up with swiss drugmaker novartis to create smart contact lenses which can track blood sugar levels. the contacts would measure glucose in tear fluid, then send the information to a wireless mobile device. it would potentially eliminate the need for finger pricks to check blood sugar levels -- which for some is necessary ten times a day. here are a few stories that are trending online this morning ... the bulls have released carlos boozer after four years. boozer was a...
69
69
Jul 15, 2014
07/14
by
FBC
tv
eye 69
favorite 0
quote 0
first up, novartis and google have joined forces, fascinating, smart contact lenses.ew eye war will monitor blood sugar levels for die bets i cans and do couple other things. >>> the nba is seeking to double tv rights fees it receives from disney and time warner. disney is paying 485 million a year. turner is handing over 445 million a year. >>> alibaba teaming up with lions gate entertainment to launch a subscription service in china. that will be lyon's entertainment world and specific to the alibaba set-top boxes. >>> facebook will scan databases and send age and ginder viewers to nielsen to help advertisers learn more about who is watching shows online. >>> whatsapp competitor lime values for ipo, valued at $9.8 billion. the smartphone messaging app set up after japan's 2011 tsunami disaster wants to list on new york stock exchange. that is speed read. david: one company giving a whole new meaning the to phrase sign on the dodd line. you may not know its name, employees at 90% of the world's biggest companies used its products in 40,000 new users join its network
first up, novartis and google have joined forces, fascinating, smart contact lenses.ew eye war will monitor blood sugar levels for die bets i cans and do couple other things. >>> the nba is seeking to double tv rights fees it receives from disney and time warner. disney is paying 485 million a year. turner is handing over 445 million a year. >>> alibaba teaming up with lions gate entertainment to launch a subscription service in china. that will be lyon's entertainment world...
99
99
Jul 25, 2014
07/14
by
FBC
tv
eye 99
favorite 0
quote 0
blake lively set i am no editor, novartis and, no expert and no arbiter of what you should buy.doing this? >> because it is relatable. she is not the expert like you and i are not the experts. dimensions of a lot of celebrities are doing this and gwyneth paltrow was the one that started this trend with her website which sometimes gets made fun of because it has ridiculously expensive items but it also has a huge following. reported the hundreds of thousands of college-educated women who go on the site and that is the demographic that you want. you are trying to sell things. and ecommerce site, magazine, it is charitable. melissa: i wonder because the show is called money. what is their financial plan behind all this? if you look at gwyneth paltrow, i don't know how much he actually sells, people make fun of her. blake lively is beautiful and wonderful blue eyes the 97% of my day generally online shopping so i went to her website today and was looking at it and it was like she sold chocolate sauce and there was acute care of earrings and they were sold out and a skirt they hoped
blake lively set i am no editor, novartis and, no expert and no arbiter of what you should buy.doing this? >> because it is relatable. she is not the expert like you and i are not the experts. dimensions of a lot of celebrities are doing this and gwyneth paltrow was the one that started this trend with her website which sometimes gets made fun of because it has ridiculously expensive items but it also has a huge following. reported the hundreds of thousands of college-educated women who...
52
52
Jul 21, 2014
07/14
by
BLOOMBERG
tv
eye 52
favorite 0
quote 0
has been on i thought the most interesting pharma deal was novartis about six or seven weeks ago whenced for deals in one day in the multibillion-dollar range. they were repositioning a strong getwhere they may be won't to the top in our market space. >> is that why we have seen these stocks actually go up? >> yes, they are strategic. there have been a few examples but generally buyers are rewarded in their stock price because it is strategic but utilizing cash that is otherwise sitting on the balance sheet earning nothing. financing is very cheap and they've got synergy especially in pharma which is so research and development intensive. ge is relatively flat after the deal. where is the next slew of deals going to come from? will it still be pharmaceuticals? question is where a deal will not happen. and health care in particular, we are going through a phase where something has to happen. a lot of what is going on to try to reduce the cost of the delivery of the drug or the service or whatever because of obama care and everything else. health care has gotten too expensive. and one t
has been on i thought the most interesting pharma deal was novartis about six or seven weeks ago whenced for deals in one day in the multibillion-dollar range. they were repositioning a strong getwhere they may be won't to the top in our market space. >> is that why we have seen these stocks actually go up? >> yes, they are strategic. there have been a few examples but generally buyers are rewarded in their stock price because it is strategic but utilizing cash that is otherwise...
120
120
Jul 16, 2014
07/14
by
FBC
tv
eye 120
favorite 0
quote 0
novartis says the parent company makes everyday contact lenses.e deal. look at google. we have a new number for the valuation of aly baba. try $150 billion. we called the company the chinese amazon. yahoo! has a big stake in ali baba. nonetheless, yahoo! is down. we have to check out intel. they shipped a record number of profits last quarter.in they are up. back in a moment. ♪ i'd lift my arm and the pain back here was excruciating. i couldn't lift my arms to drum or to dance. when i was drumming and moving my rib cage and my arms like this it hurt across here. when i went to the doctor and said what's happening to me his first question was "did you have chickenpox?" i didn't even really know what shingles was. i thought it was something that, you know, old people got. i didn't want to have clothes on. i didn't want to have clothes off. if someone asked me "let's go dancing" that would have been impossible. stuart: intel is helping out all of the semi conductor stocks. nicole: that is right. they came out with their numbers. better than expected.
novartis says the parent company makes everyday contact lenses.e deal. look at google. we have a new number for the valuation of aly baba. try $150 billion. we called the company the chinese amazon. yahoo! has a big stake in ali baba. nonetheless, yahoo! is down. we have to check out intel. they shipped a record number of profits last quarter.in they are up. back in a moment. ♪ i'd lift my arm and the pain back here was excruciating. i couldn't lift my arms to drum or to dance. when i was...
214
214
Jul 17, 2014
07/14
by
CNBC
tv
eye 214
favorite 0
quote 1
drugmaker novartis said revenue from new products will offset generic competition for its popular bloodpressure medicine. that stock lower by 1.3% in the session. confirming full year goals after first half profits rose by 13%, givaudan has sales are strong with fragrances. >>> israel will observe a five-hour cease-fire after a shelling kills four boys on a gaza beach. the humanitarian truce is requested by the united nations and the israeli military said it would respond firmly and decisi decisively. we've got some breaking news. the press is reporting two rockets have been fired from gaza into israel. they're quoting the israeli police. hadley gamble joins us now. hadley, i believe that's news to you, too. so we've seen rocket fire now from gaza into israel. the cease-fire no longer holding. >> and this is something that is not totally unexpected. the israelis said if the cease-fire is brokingen, we'll deal with this decisively. the problem here, essentially, is that we've seen no progress coming out of cairo, coming out of these negotiations. mahmoud abbas is there. we've seen no pro
drugmaker novartis said revenue from new products will offset generic competition for its popular bloodpressure medicine. that stock lower by 1.3% in the session. confirming full year goals after first half profits rose by 13%, givaudan has sales are strong with fragrances. >>> israel will observe a five-hour cease-fire after a shelling kills four boys on a gaza beach. the humanitarian truce is requested by the united nations and the israeli military said it would respond firmly and...
150
150
Jul 24, 2014
07/14
by
CNBC
tv
eye 150
favorite 0
quote 0
acquisition a year culminating in a large acquisition we announced in april, our intention to buy novartiso when that closes, early next year, we will be number two in that industry, but if you look at our growth, the growth has come about half from those acquisitions, and about half from our organic internal pipeline. >> john, i should point out, people have even looked at you as a potential target, after pfizer's deal for astrazeneca fell apart. it's something that i've seen speculated in certain places, certainly nothing that i've seen substantiated but have you heard from pfizer? >> no. we've not heard from pfizer. we don't aim to be anyone's target. we've made it clear that we believe the best path for eli lilly and company is to remain independent, to continue to invest appropriately in r&d, and generate the kind of growth that shareholders expect. so, we've been clear, becky, back to prozac days that we believe that there's no evidence that supports the long-term benefits of these large-scale combinations. certainly in the short-term, you do see benefits. but our business has longti
acquisition a year culminating in a large acquisition we announced in april, our intention to buy novartiso when that closes, early next year, we will be number two in that industry, but if you look at our growth, the growth has come about half from those acquisitions, and about half from our organic internal pipeline. >> john, i should point out, people have even looked at you as a potential target, after pfizer's deal for astrazeneca fell apart. it's something that i've seen speculated...